Edwards Lifesciences LLC and Endogad Research PTY Limited (collectively, “Edwards”) appeal from the judgment of the United States District Court for the Northern District of California granting summary judgment of noninfringement of several claims of U.S. Patents 6,582,458 (“the ’458 patent”); 6,613,073 (“the ’073 patent”); 6,685,736 (“the ’736 patent”); and 6,689,158 (“the ’158 patent”). See Edwards Lifesciences LLC v. Cook, No. C 03-03817 JSW, 2007 U.S. Dist. Lexis 55634 (N.D. Cal. July 23, 2007) (“Claim Construction Order”); Edwards Lifesciences LLC v. Cook, No. C 03-03817 JSW, 2008 U.S. Dist. Lexis 21248 (N.D. Cal. Mar. 18, 2008) (“Order Granting Cook Summary Judgment”); Edwards Lifesciences LLC v. Cook, No. C 03-03817 JSW, 2008 U.S. Dist. Lexis 70130 (N.D. Cal. Sept. 15, 2008) (“Order Granting Gore Summary Judgment”). Because the court correctly construed certain claim terms and correctly determined that Cook Incorporated’s and W.L. Gore & Associates, Inc.’s (collectively, “Appellees’”) devices did not infringe under those constructions, we affirm.
